2. What disease is coded by the Phenotype MIM number: a. 203500 - ALKAPTONURIA 3. Give the gene/ locus name of the disease - HOMOGENTISIC ACID OXIDASE DEFICIENCY 4. Summarize not more than 5 sentences the basic characteristic of the disease? Alkaptonuria, found on chromosome 3q13, is an inborn error of metabolism characterized by accumulation of homogentisic acid. It is an autosomal recessive metabolic disorder due to a deficiency of homogentisic acid 1,2 dioxygenase at molecular level. This means that the body cannot process can lead to leading to darkened urine, pigmentation of connective tissue, joint and spine arthritis, destruction of cardiac valves, and urolithiasis. According to clinical study, Severity of disease increases at age 30 above and rapidly increases in men than in women. 5. Give the complete bibliography entry of the first journal that described the disease Abe, Y., Oshima, N., Hatanaka, R., Amako, T., Hirohata, R. Thirteen cases of alkaptonuria from one family tree with special reference to osteo-arthrosis alkaptonuria. J. Bone Joint Surg. Am. 42: 817-831, 1960. [PubMed:13848727, related citations] 6. Summarize in not more than 5 sentences an example of the latest available treatment or management of the disease Until now, no effective treatment regimen has yet been developed for this disorder. However, use of genetic engineering by replacing the missing enzyme would be a solution. Also, a case study that 2(-2-nitro-4-trifluoromethylbenzoyl)-1,3- cyclohexanedione (NTBC), a potent inhibitor of p-hydroxyphenylpyruvate dioxygenase, which catalyzes the formation of homogentisic acid from p-hydroxyphenylpyruvic acid was adopted as a possible therapeutic agent for alkaptonuria. 7. Give the complete bibliography entry of the journal described on no.6 Suzuki, Y., Oda, K., Yoshikawa, Y., Maeda, T., Suzuki, T. A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria. J. Hum. Genet. 44: 79-84, 1999. [PubMed: 10083729, related citations]